openPR Logo
Press release

Implantable Neurostimulation Devices Market Forecast and Segments Till 2020

01-05-2017 04:50 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Implantable Neurostimulation Devices Market Forecast

Neurostimulation devices are used for the modulation of electric signals communicated from the brain to different organs and vice-versa for improving biological functions. Neurostimulation was used externally for controlling pain and improving muscular tone through devices such as transcutaneous electrical nerve stimulation (TENS); however greater understanding of the biological communication channels and creation of potential inside the body gave an avenue of controlling certain disorders of muscle, sensation and control of pain. Neurostimulation devices comprises a generator and electrodes or leads for delivering therapeutic doses of current and a remote device for controlling the rate and amount of current.

The current market for neurostimulation is divided into three therapeutic applications first of which is Deep Brain Stimulation (DBS). This is intended for indications of Parkinson?s disease, epilepsy, tremor, dystonia and depression among other brain disorders. The second application is Spinal Nerve Stimulation or Spinal Cord Stimulation (SCS) that accounts for the largest market share today. Spinal Cord Stimulation targets chronic pain in certain locations or cases of pain in entire body such as fibromyalgia. The third notable application of neurostimulation is sacral nerve stimulation which is directed at incontinence and uncontrolled urges for urination or defecation. Sacral nerve stimulation accounts for the least share in the global neurostimulation market. An upcoming application in this area is the Vagus Nerve Stimulation achieved from implanting electrodes on the vagus nerve. The technique is used for treatment of depression and epilepsy. The global neurostimulation market estimates for 2014 were at US$ 4.5 billion.

The biggest players in this market are St. Jude Medical, Boston Scientific and Medtronic Inc. Other notable players include Spinal Modulation, BioControl Medical, Synapse Biomedical Inc and Nevro Corporation among several other innovative companies.Collaboration with Spinal Modulation has driven the sales for St. Jude Medical?s neurostimulation segment in 2013. A positive picture can be envisioned for this technology in coming years as it becomes safer, more advanced and increases in acceptance. Overall analysis indicates the market has been doing well, however our social media analysis on the segment indicates an increasing population treated with neurostimulation is still suffering with original problems with or without the amplification in pain or discomfort caused by the surgical procedure of implanting the device. Cost, reimbursement and post surgical success remains a strong challenge for companies in coming years. Along with this, pain management through other means such as Unani medicine and pharmaceuticals also acts as a strong substitute for techniques such as spinal cord stimulation.

Click For Request TOC@

SA-BRC analyses the market for neurostimulation devices in North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. Medical tourism is pushing the growth of neurostimulation procedures in Latin America and Asia-Pacific region. However, North America and Europe continue to lead the market primarily due to greater adoption of the technology and affordability of the device to a large number of people. A large number of private insurers are willing to reimburse the technology, thus making it more accessible to people in United States, Canada, United Kingdom, France, Germany and Japan among other developed countries.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Neurostimulation Devices Market Forecast and Segments Till 2020 here

News-ID: 406616 • Views: 304

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Neurostimulation

Neurostimulation Device Market Opportunity Assessment Study - P&S Intelligence
The neurostimulation device market is growing, due to increasing geriatric population, increasing prevalence of chronic pain, and increasing incidents of neurological disorders. In addition, the awareness about mental diseases and their treatment is also increasing across the globe. Explore Report with Detailed TOC on “Global Neurostimulation Device Market” at: The information and data in the publication “Global Neurostimulation Device Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the
Neurostimulation Market Forecast Research Reports Offers Key Insights 2025
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. Neurostimulation is a highly potential treatment option for patients who do not obtain relief from medications and surgical therapies. It improves the quality of life of patients who are severely paralyzed or suffering from intense loss of various sense organs. Therefore, neurostimulation is highly instrumental in artificial vision, hearing
Global Neurostimulation Devices Market overview
Neurostimulation devices are commonly used to diagnose and treat disorders of the autonomic nervous system, the central nervous system (CNS) and the peripheral nervous system (PNS). Neurostimulation devices are used to stimulate brain cells and administer medications. Diseases that do not respond to routine pharmacological treatments require advanced stimulation devices to treat them. The demand for such devices is increasing, particularly for the treatment of chronic neurological conditions such as
Neurostimulation Market Boosting the Healthcare Industry Worldwide
Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological technologies, the global market for neurostimulation is expected to reach a market size valued at USD 7.3 billion in year 2018. The market is expected to grow at a healthy CAGR of 8.2% from 2012 – 2018. It was estimated at USD 4.2 billion in 2011. View Report: Medical devices manufacturing companies and their
Neurostimulation Devices Market - Opportunity Analysis, 2016–2025
Neurostimulation therapy is used for treatment and diagnosis of nervous disorder. It reduces chronic pain associated with conditions such as Parkinson’s disease, epilepsy, nociceptive pain, neuropathic pain, and depression. It helps to improve quality of life of patients suffering from paralysis, obesity, and severe loss of sensory organs. Neurostimulation devices is a key element used in neural prosthetics for artificial vision, artificial limbs, and hearing aids. They include implantable and
Neurostimulation Market Forecast and Segments, 2012 - 2018
Driven by rising health awareness and continuous disruptive innovations made in the field of medical and biological technologies, the global market for neurostimulation is expected to reach a market size valued at USD 7.3 billion in year 2018. The market is expected to grow at a healthy CAGR of 8.2% from 2012 – 2018. It was estimated at USD 4.2 billion in 2011. Medical devices manufacturing companies and their technological affiliates